Trulicity is a once-weekly injectable medicine used to enhance blood sugar management in adults with sort 2 diabetes. It’s a glucagon-like peptide-1 (GLP-1) receptor agonist, which suggests it really works by mimicking the consequences of a hormone referred to as GLP-1, which is launched by the intestine after consuming. GLP-1 helps to manage blood sugar ranges by slowing down the emptying of the abdomen, decreasing urge for food, and growing insulin manufacturing.
Trulicity is efficient in decreasing blood sugar ranges and decreasing the chance of cardiovascular occasions in individuals with sort 2 diabetes. It is usually well-tolerated, with the commonest negative effects being gentle to average gastrointestinal signs, resembling nausea, vomiting, and diarrhea. Trulicity isn’t beneficial for individuals with sort 1 diabetes or diabetic ketoacidosis.
